SEC Form 4 · accession 0000899243-18-024906
Deciphera Pharmaceuticals, Inc. · DCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen B. Ruddy
Officer — Chief Technical Officer
Period of report
May 29, 2018
Accepted (ET)
Sep 20, 2018 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001654151
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $26.50 | May 29, 2018 | A | 90,000 | A | — | May 28, 2028 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan. 25% of the shares shall vest on May 29, 2019 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to continued service through such dates.